Filing Flows › Bausch Health Companies (BHC) › Q2 2026 › vs Q2 2025
Bausch Health Companies (BHC) Q2 2026 vs Q2 2025 (year over year)
Bausch Health Companies's revenue rose $322M (+13%) from $2.5B in Q2 2025 to $2.9B in Q2 2026. The biggest changes: Product sales +$321M (+13%); Other revenues +$1.0M (+4%). Operating margin 25.9% against 17.5% (+8.4 pts).
Bausch Health Companies, Q2 2026: revenue $2.9B (+13% year over year), operating margin 25.9%, net earnings $258M, operating cash flow $670M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 25.9% | 17.5% | +8.4 pts |
| Net margin | 9.0% | 5.8% | +3.2 pts |
| Free cash flow margin | 20.8% | 7.5% | +13.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product sales | $2.8B | $2.5B | $321M | +13% |
| Other revenues | $27.0M | $26.0M | $1.0M | +4% |
| Revenue | $2.9B | $2.5B | $322M | +13% |
| Operating profit | $740M | $444M | $296M | +67% |
| Costs & expenses | $2.1B | $2.1B | $26.0M | +1% |
| Pre-tax earnings | $348M | $140M | $208M | +149% |
| Other expense, net | $392M | $304M | $88.0M | +29% |
| Research & development | $173M | $159M | $14.0M | +9% |
| SG&A | $907M | $894M | $13.0M | +1% |
| Other operating costs | $1.0B | $1.0B | −$1.0M | -0.1% |
| Net earnings | $258M | $148M | $110M | +74% |
| Minority interests | $2.0M | −$20.0M | $22.0M | — |
| Income tax | $88.0M | $12.0M | $76.0M | +633% |
| Depreciation & amortization | $281M | $307M | −$26.0M | -8% |
| Share-based compensation | $54.0M | $46.0M | $8.0M | +17% |
| Working capital & other | $77.0M | −$212M | $289M | — |
| Operating cash flow | $670M | $289M | $381M | +132% |
| Free cash flow (OCF − capex) | $593M | $190M | $403M | +212% |
| Capital expenditures | $77.0M | $99.0M | −$22.0M | -22% |
Questions
How much did Bausch Health Companies's revenue grow year over year in Q2 2026?
Bausch Health Companies's revenue rose $322M (+13%) from $2.5B in Q2 2025 to $2.9B in Q2 2026.
What drove Bausch Health Companies's revenue change in Q2 2026?
Product sales +$321M (+13%); Other revenues +$1.0M (+4%).